10.10.2024 11:37:11

EQS-AFR: MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: MeVis Medical Solutions AG / Preliminary announcement on the disclosure of financial statements
MeVis Medical Solutions AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

10.10.2024 / 11:37 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


MeVis Medical Solutions AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: January 30, 2025
Address: https://www.mevis.de/investor-relations/finanzberichte

Report Type: Financial report (half-year/Q2)

Language: German
Date of disclosure: May 27, 2025
Address: https://www.mevis.de/investor-relations/finanzberichte


10.10.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Internet: http://www.mevis.de

 
End of News EQS News Service

2006211  10.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2006211&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu MeVis Medical Solutions AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

MeVis Medical Solutions AG 24,60 0,82% MeVis Medical Solutions AG